← FDA Drug Approvals (Drugs@FDA)

MEMANTINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEDLEY PHARMS · Approved 2020-08-31

Drug application

FDA Application #

ANDA210319

Application type

Abbreviated New Drug Application (Generic)

Brand name

MEMANTINE HYDROCHLORIDE

Generic name

MEMANTINE HYDROCHLORIDE ORAL

Active ingredients

MEMANTINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

MEDLEY PHARMS

Manufacturer

Seton Pharmaceuticals

First approval

2020-08-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown